Amplexd Therapeutics

Private

Gaithersburg, MarylandHealthcare & Life Scienceshttps://amplexd.com/

Last Round

Seed

May 20, 2024

Total Funding Raised

$2M

Company Overview

Amplexd Therapeutics is a biotechnology company that develops non-invasive, accessible therapies for HPV-induced cervical intraepithelial neoplasia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

cervical intraepithelial neoplasiaCINHPV treatmentphotodynamic therapyPDTvaginal suppositorycervical dysplasianon-invasive surgeryepigallocatechin gallateEGCgbiotech startupwomen's health techfemtechprecancerous lesionclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplexd Therapeutics Comparables

Compare Amplexd Therapeutics with similar companies based on industry and business-model similarity.

Amplexd Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Antiva Biosciences	84%
Frantz Medical Group	82%
Gynion	78%

View all Comparables

Amplexd Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	May 20, 2024

View all Funding Rounds

Amplexd Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Amplexd Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amplexd Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersGaithersburg, Maryland

Employee Range2

Year Founded2022

Last FundingMay 20, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?